Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment
Authors
Keywords
Hereditary leiomyomatosis and renal cell cancer, Fumarate hydratase, Type 2 papillary renal cell cancer, Tricarboxylic acid cycle, Surveillance, Nephrectomy, Targeted therapy
Journal
Familial Cancer
Volume 13, Issue 4, Pages 637-644
Publisher
Springer Nature
Online
2014-07-10
DOI
10.1007/s10689-014-9735-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer
- (2014) Ying-Bei Chen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Influence of Metabolism on Epigenetics and Disease
- (2013) William G. Kaelin et al. CELL
- Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer--Targeting the Warburg Effect in Cancer
- (2013) W. M. Linehan et al. CLINICAL CANCER RESEARCH
- Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
- (2013) Luis Jaime Castro-Vega et al. HUMAN MOLECULAR GENETICS
- Hereditary papillary renal cell carcinoma primarily diagnosed in a cervical lymph node: a case report of a 30-year-old woman with multiple metastases
- (2013) Carl Ludwig Behnes et al. BMC Urology
- Targeted therapeutic strategies for the management of renal cell carcinoma
- (2012) Eric A. Singer et al. CURRENT OPINION IN ONCOLOGY
- Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Inhibition of -KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
- (2012) M. Xiao et al. GENES & DEVELOPMENT
- Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
- (2012) W. M. Linehan GENOME RESEARCH
- Integration of Surgery and Systemic Therapy for Renal Cell Carcinoma
- (2012) Patrick A. Kenney et al. UROLOGIC CLINICS OF NORTH AMERICA
- Defining an Individualized Treatment Strategy for Metastatic Renal Cancer
- (2012) Brian Hu et al. UROLOGIC CLINICS OF NORTH AMERICA
- The emerging role of fumarate as an oncometabolite
- (2012) Ming Yang et al. Frontiers in Oncology
- The Glycolytic Shift in Fumarate-Hydratase-Deficient Kidney Cancer Lowers AMPK Levels, Increases Anabolic Propensities and Lowers Cellular Iron Levels
- (2011) Wing-Hang Tong et al. CANCER CELL
- Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome
- (2011) Victoria M. Raymond et al. Familial Cancer
- Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
- (2011) Karin Y. van Spaendonck-Zwarts et al. Familial Cancer
- Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics
- (2011) Heli J. Lehtonen Familial Cancer
- Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma
- (2011) B. Gardie et al. JOURNAL OF MEDICAL GENETICS
- Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status
- (2011) Chiara Bardella et al. JOURNAL OF PATHOLOGY
- Progress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease
- (2011) Dominique Joly et al. JOURNAL OF UROLOGY
- Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC
- (2011) Toshinari Yamasaki et al. Nature Reviews Urology
- Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis
- (2010) DL Smit et al. CLINICAL GENETICS
- A Novel Missense Mutation in Fumarate Hydratase in an Italian Patient with a Diffuse Variant of Cutaneous Leiomyomatosis (Reed’s Syndrome)
- (2010) F. Rongioletti et al. DERMATOLOGY
- Cutaneous papules, uterine fibroids, and renal cell cancer: one family's tale
- (2010) Meltem Onder et al. LANCET
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome
- (2009) Pia Vahteristo et al. Familial Cancer
- Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient
- (2009) Ismail Alrashdi et al. Familial Cancer
- Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell Cancer
- (2008) Laveta Stewart et al. ARCHIVES OF DERMATOLOGY
- The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency
- (2008) Jean-Pierre Bayley et al. BMC Medical Genetics
- Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer
- (2008) Taru Ahvenainen et al. CANCER GENETICS AND CYTOGENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More